<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NUTRESTORE- glutamine powder, for solution </strong><br>Emmaus Medical, Inc.<br></p></div>
<div id="Highlights" class="Highlights"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1>HIGHLIGHTS OF PRESCRIBING INFORMATION</h1>
<div class="HighlightsDisclaimer">These highlights do not include all the information needed to use NUTRESTORE® safely and effectively. See full prescribing information for NUTRESTORE®.<br><br> NUTRESTORE® [L-glutamine powder for oral solution]<br> Initial U.S. Approval: 2004</div>
<div></div>
<div class="HighlightSection">
<h1 class="Highlights"><span>INDICATIONS AND USAGE</span></h1>
<div>
<p class="Highlighta">NutreStore® is an amino acid indicated for: </p>
<ul class="Disc"><li>the treatment of Short Bowel Syndrome in patients receiving specialized nutritional support when used in conjunction with a recombinant human growth hormone that is approved for this indication (<a href="#S1">1</a>)</li></ul>
</div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE AND ADMINISTRATION</span></h1>
<div><ul class="Disc">
<li>30 g daily in divided doses (5 g taken 6 times each day orally) for up to 16 weeks (<a href="#S2">2</a>)</li>
<li>Each dose should be reconstituted in 8 oz (250 mL) of water prior to consumption (<a href="#S2">2</a>)</li>
<li>Should be taken with meals or snacks at 2- to 3-hour interval while awake (<a href="#S2">2</a>)</li>
</ul></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>DOSAGE FORMS AND STRENGTHS</span></h1>
<div><ul class="Disc"><li>Pre-printed paper-foil-plastic laminate packets: 5 g powder (<a href="#S3">3</a>)</li></ul></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>CONTRAINDICATIONS</span></h1>
<div><ul class="Disc"><li>None (<a href="#S4">4</a>)</li></ul></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>WARNINGS AND PRECAUTIONS</span></h1>
<div><ul class="Disc"><li>Routine monitoring of renal and hepatic function is recommended in patients receiving lPN, particularly in those with renal or <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic impairment</span> (<a href="#S5.1">5.1</a>)</li></ul></div>
<div></div>
</div>
<div class="HighlightSection">
<h1 class="Highlights"><span>ADVERSE REACTIONS</span></h1>
<div>
<p class="Highlighta">Most common adverse reactions are (<a href="#S6.1">6.1</a>): </p>
<ul class="Disc">
<li>In initial four (4) weeks (incidence &gt;10%): <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span>, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, tenesmus, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="194382" conceptname="External hemorrhoids">hemorrhoids</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">mouth dry</span>.</li>
<li>In weeks 5-18 (incidence &gt;10%): <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, tenesmus, <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">pancreatitis</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, Crohn's disease aggravated, <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">gastric ulcer</span>, <span class="product-label-link" type="condition" conceptid="4295370" conceptname="Gastrointestinal fistula">gastrointestinal fistula</span>.</li>
</ul>
<br><p class="Highlighta"><span class="Bold">To report SUSPECTED ADVERSE REACTIONS, contact Emmaus Medical, Inc. at 1-877-420-6493 or FDA at 1-800-FDA-1088 or<span class="Italics"> www.fda.gov/medwatch.</span></span> </p>
</div>
<div></div>
</div>
<div></div>
<div>
<div><div></div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
<div></div>
<div></div>
<div>
<div></div>
<div></div>
<div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
<div></div>
</div>
</div>
<div><div></div></div>
<div><div></div></div>
<div><div></div></div>
<div><div></div></div>
<div></div>
<div></div>
<div></div>
<p class="HighlightsSeeReference">See 17 for PATIENT COUNSELING INFORMATION and FDA-approved patient labeling.</p>
<p class="HighlightsRevision">Revised: 7/2014</p>
</div></td></tr></table></div>
<div id="Index" class="Index"><table cellspacing="5" cellpadding="5" width="100%" style="table-layout:fixed"><tr><td align="left" valign="top"><div>
<h1 class="Colspan">FULL PRESCRIBING INFORMATION: CONTENTS<a href="#footnote-content" name="footnote-reference-content">*</a>
</h1>
<h1><a href="#section-1" class="toc">1 INDICATION AND USAGE</a></h1>
<h1><a href="#section-2" class="toc">2 DOSAGE AND ADMINISTRATION</a></h1>
<h1><a href="#section-3" class="toc">3 DOSAGE FORMS AND STRENGTHS</a></h1>
<h1><a href="#section-4" class="toc">4 CONTRAINDICATIONS</a></h1>
<h1><a href="#section-5" class="toc">5 WARNINGS AND PRECAUTIONS</a></h1>
<h2><a href="#section-5.1" class="toc">5.1 Increased Serum <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">Ammonia</span> and Glutamate</a></h2>
<h1><a href="#section-6" class="toc">6 ADVERSE REACTIONS</a></h1>
<h2><a href="#section-6.1" class="toc">6.1 Clinical Trials Experience</a></h2>
<h1><a href="#section-7" class="toc">7 DRUG INTERACTIONS</a></h1>
<h1><a href="#section-8" class="toc">8 USE IN SPECIFIC POPULATIONS</a></h1>
<h2><a href="#section-8.1" class="toc">8.1 Pregnancy</a></h2>
<h2><a href="#section-8.2" class="toc">8.2 Labor and Delivery</a></h2>
<h2><a href="#section-8.3" class="toc">8.3 Nursing Mothers</a></h2>
<h2><a href="#section-8.4" class="toc">8.4 Pediatric Use</a></h2>
<h2><a href="#section-8.5" class="toc">8.5 Geriatric Use</a></h2>
<h2><a href="#section-8.6" class="toc">8.6 <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">Hepatic Impairment</span></a></h2>
<h2><a href="#section-8.7" class="toc">8.7 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span></a></h2>
<h1><a href="#section-9" class="toc">10 OVERDOSAGE</a></h1>
<h1><a href="#section-10" class="toc">11 DESCRIPTION</a></h1>
<h1><a href="#section-11" class="toc">12 CLINICAL PHARMACOLOGY</a></h1>
<h2><a href="#section-11.1" class="toc">12.1 Mechanism of Action</a></h2>
<h2><a href="#section-11.2" class="toc">12.2 Pharmacodynamics</a></h2>
<h2><a href="#section-11.3" class="toc">12.3 Pharmacokinetics</a></h2>
<h1><a href="#section-12" class="toc">13 NONCLINICAL TOXICOLOGY</a></h1>
<h2><a href="#section-12.1" class="toc">13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</a></h2>
<h1><a href="#section-13" class="toc">14 CLINICAL STUDIES</a></h1>
<h2><a href="#section-13.1" class="toc">14.1 Short Bowel Syndrome</a></h2>
<h1><a href="#section-14" class="toc">16 HOW SUPPLIED/STORAGE AND HANDLING</a></h1>
<h1><a href="#section-15" class="toc">17 PATIENT COUNSELING INFORMATION</a></h1>
<h2><a href="#section-15.1" class="toc">17.1 Dosing Instructions</a></h2>
<dl class="Footnote">
<dt><a href="#footnote-reference-content" name="footnote-content">*</a></dt>
<dd>Sections or subsections omitted from the full prescribing information are not listed.</dd>
</dl>
</div></td></tr></table></div>
<div class="Contents">
<h1>FULL PRESCRIBING INFORMATION</h1>
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="S1"></a><a name="section-1"></a><p></p>
<h1>1 INDICATION AND USAGE</h1>
<p class="First">NutreStore<span class="Sup">®</span> [L-glutamine powder for oral solution] is indicated for the treatment of Short Bowel Syndrome (SBS) in patients receiving specialized nutritional support when used in conjunction with a recombinant human growth hormone that is approved for this indication [<span class="Italics">see<a href="#S2"> Dosage and Administration (2)</a></span>].</p>
<p>NutreStore and recombinant human growth hormone (rhGH) therapy should be used in conjunction with optimal management of SBS. Optimal management of SBS may include a specialized oral diet, enteral feedings, parenteral nutrition, fluid and micronutrient supplements. A specialized oral diet may consist of a high carbohydrate, low-fat diet, adjusted for individual patient requirements and preferences.</p>
<p>Routine monitoring of renal and hepatic function is recommended in patients receiving NutreStore and intravenous parenteral nutrition (IPN), particularly in those with renal or <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic impairment</span>. Glutamine is metabolized to glutamate and <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">ammonia</span>, which may increase in patients with hepatic dysfunction.</p>
<p>The safety and efficacy of NutreStore have not been studied beyond 16 weeks of treatment.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="S2"></a><a name="section-2"></a><p></p>
<h1>2 DOSAGE AND ADMINISTRATION</h1>
<p class="First">NutreStore should be administered as a cotherapy with rhGH (see prescribing information for somatropin [rDNA origin)] for injection) followed by continued NutreStore for up to 16 weeks.</p>
<p>The recommended dosage of NutreStore is 30 g daily in divided doses (5 g taken 6 times each day orally) for up to 16 weeks. Each dose of NutreStore (5 g) should be reconstituted in 8-oz (250-mL) of water prior to consumption.</p>
<p>NutreStore should be taken with meals or snacks at 2- to 3-hour intervals while awake. The volume of water may be varied according to the patient's preference. In the event of a patient's transient intolerance to oral intake, a dose may be delayed for up to 2 hours.</p>
</div>
<div class="Section" data-sectionCode="43678-2">
<a name="S3"></a><a name="section-3"></a><p></p>
<h1>3 DOSAGE FORMS AND STRENGTHS</h1>
<p class="First">NutreStore is supplied in preprinted paper-foil-plastic laminate packets containing 5 g of L-glutamine powder.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="S4"></a><a name="section-4"></a><p></p>
<h1>4 CONTRAINDICATIONS</h1>
<p class="First">None.</p>
</div>
<div class="Section" data-sectionCode="43685-7">
<a name="S5"></a><a name="section-5"></a><p></p>
<h1>5 WARNINGS AND PRECAUTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="S5.1"></a><a name="section-5.1"></a><p></p>
<h2>5.1 Increased Serum <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">Ammonia</span> and Glutamate</h2>
<p class="First">Glutamine is metabolized to glutamate and <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">ammonia</span>, which may increase in patients with hepatic dysfunction. Therefore, routine monitoring of renal and hepatic function is recommended in patients receiving intravenous parenteral nutrition (IPN) and NutreStore, particularly in those with renal or <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">hepatic impairment</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="S6"></a><a name="section-6"></a><p></p>
<h1>6 ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="S6.1"></a><a name="section-6.1"></a><p></p>
<h2>6.1 Clinical Trials Experience</h2>
<p class="First">Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice</p>
<p>Table 1 provides the number of subjects by system-organ class experiencing at least one adverse reaction during the 4-week treatment period of the SBS study. To be listed in Table 1, an adverse reaction must have occurred in more than 10% of subjects in any treatment group.</p>
<table width="100%">
<caption><span>Table 1 Controlled Trial Adverse Reactions - Initial 4 Week Treatment Period</span></caption>
<col align="left" valign="top" width="50%">
<col align="center" valign="top" width="15%">
<col align="center" valign="top" width="20%">
<col align="center" valign="top" width="15%">
<thead>
<tr class="First">
<th class="Lrule Rrule" align="center">Adverse Reactions</th>
<th class="Rrule" align="center">Group A</th>
<th class="Rrule" align="center">Group B</th>
<th class="Rrule" align="center">Group C</th>
</tr>
<tr class="Last">
<th class="Lrule Rrule" align="left"></th>
<th class="Rrule" align="center">rhGH+SOD<a name="footnote-reference-1" href="#footnote-1" class="Sup">*</a><br>N=16<br>n (%)</th>
<th class="Rrule" align="center">rhGH+SOD[GLN]<a href="#footnote-1" class="Sup">*</a><br>N=16<br>n (%)</th>
<th class="Rrule" align="center">SOD[GLN]<a href="#footnote-1" class="Sup">*</a><br>N=9<br>n (%)</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="4">GROUP A: rhGH + SOD for 4 weeks followed by SOD for 12 weeks.</td></tr>
<tr><td align="left" colspan="4">GROUP B: rhGH + SOD [GLN] for 4 weeks followed by SOD [GLN] for 12 weeks.</td></tr>
<tr class="Last"><td align="left" colspan="4">GROUP C: rhGH placebo + SOD [GLN] for 4 weeks followed by SOD [GLN) for 12 weeks.</td></tr>
<tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-1" href="#footnote-reference-1">*</a></dt>
<dd>SOD [GLN) = Specialized Oral Diet supplemented with Glutamine; rhGH + SOD = Human Growth Hormone plus Specialized Oral Diet; rhGH + SOD [GLN] = Human Growth Hormone plus Specialized Oral Diet supplemented with Glutamine</dd>
</dl></td></tr>
</tfoot>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left"><span class="Bold">Total Number of Subjects with At Least One Adverse Reaction</span></td>
<td class="Rrule" align="center">16 (100)</td>
<td class="Rrule" align="center">16 (100)</td>
<td class="Rrule" align="center">8 (89)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Body as a Whole: General Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">15 (94)</span></td>
<td class="Rrule" align="center"><span class="Bold">15 (94)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (44)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span>, Peripheral</td>
<td class="Rrule" align="center">11 (69)</td>
<td class="Rrule" align="center">13 (81)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span>, Facial</td>
<td class="Rrule" align="center">8 (50)</td>
<td class="Rrule" align="center">7 (44)</td>
<td class="Rrule" align="center">0(0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Chest Pain</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">2 (22)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="134736" conceptname="Backache">Back Pain</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Flu-like Disorder</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">Malaise</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">Edema</span>, Generalized</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4218984" conceptname="Abdominal distension">Abdomen Enlarged</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergic Reaction</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Rigors</span> (<span class="product-label-link" type="condition" conceptid="4190045" conceptname="Rigor">Chills</span>)</td>
<td class="Rrule" align="center">0 (0) </td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Gastrointestinal System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">12 (75)</span></td>
<td class="Rrule" align="center"><span class="Bold">12 (75)</span></td>
<td class="Rrule" align="center"><span class="Bold">6 (67)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">Flatulence</span></td>
<td class="Rrule" align="center">4 (25)</td>
<td class="Rrule" align="center"> 4 (25)</td>
<td class="Rrule" align="center">2 (22)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal Pain</span></td>
<td class="Rrule" align="center">4 (25)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">5 (31)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Tenesmus</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">3 (33)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="194382" conceptname="External hemorrhoids">Hemorrhoids</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">Mouth Dry</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1(11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Musculoskeletal System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">7 (44)</span></td>
<td class="Rrule" align="center"><span class="Bold">7 (44)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span></td>
<td class="Rrule" align="center">7(44)</td>
<td class="Rrule" align="center">5 (31)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">Myalgia</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Resistance Mechanism Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">6 (38)</span></td>
<td class="Rrule" align="center"><span class="Bold">3 (19)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (44)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">3 (33)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">Infection Bacterial</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="40493255" conceptname="Viral syndrome">Infection Viral</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Moniliasis</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Application Site Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">5 (31)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4316202" conceptname="Injection site reaction">Injection Site Reaction</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">4 (25)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4316207" conceptname="Injection site pain">Injection Site Pain</span></td>
<td class="Rrule" align="center">5 (31)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Central and Peripheral <span class="product-label-link" type="condition" conceptid="376337" conceptname="Disorder of nervous system">Nervous System Disorders</span></span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold"> 4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (22)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">Dizziness</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">Headache</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Hypoasthesia</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Skin and Appendages Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (22)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Pruritis</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">Sweating Increased</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4211923" conceptname="Nail changes">Nail Disorder</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold"><span class="product-label-link" type="condition" conceptid="320136" conceptname="Disorder of respiratory system">Respiratory System Disorders</span></span></td>
<td class="Rrule" align="center"><span class="Bold">1 (6)</span></td>
<td class="Rrule" align="center"><span class="Bold">5 (31)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Metabolic and Nutritional Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">3 (19)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (6)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">Dehydration</span></td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4241197" conceptname="Thirst">Thirst</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Urinary System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (16)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="198199" conceptname="Pyelonephritis">Pyelonephritis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Psychiatric Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (6)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (22)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">2 (22)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Reproductive Disorders, Female</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="73819" conceptname="Pain of breast">Breast Pain Female</span></td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Hearing and <span class="product-label-link" type="condition" conceptid="81303" conceptname="Labyrinthine disorder">Vestibular Disorders</span></span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left">  Ear or Hearing Symptoms</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
</tbody>
</table>
<p>Table 2 summarizes the number of subjects by system-organ class who experienced an AR during weeks 5 to 18 of the randomized, controlled SBS study. To be listed in Table 2, an AR must have occurred in more than 10% of subjects in any treatment group.</p>
<table width="100%">
<caption><span>Table 2 Controlled Trial Adverse Reactions -Weeks 5 to 18</span></caption>
<col align="left" valign="top" width="50%">
<col align="center" valign="top" width="15%">
<col align="center" valign="top" width="20%">
<col align="center" valign="top" width="15%">
<thead>
<tr class="First">
<th class="Lrule Rrule" align="center">Adverse Reactions</th>
<th class="Rrule" align="center">Group A</th>
<th class="Rrule" align="center">Group B</th>
<th class="Rrule" align="center">Group C</th>
</tr>
<tr class="Last">
<th class="Lrule Rrule" align="left"></th>
<th class="Rrule" align="center">rhGH+SOD<a name="footnote-reference-2" href="#footnote-2" class="Sup">*</a><br>N=15<br>n (%)</th>
<th class="Rrule" align="center">rhGH+SOD[GLN]<a href="#footnote-2" class="Sup">*</a><br>N=16<br>n (%)</th>
<th class="Rrule" align="center">SOD[GLN]<a href="#footnote-2" class="Sup">*</a><br>N=9<br>n (%)</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="4">GROUP A: rhCH + SOD for 4 weeks followed by SOD for 12 weeks.</td></tr>
<tr><td align="left" colspan="4">GROUP B: rhGH + SOD [GLN] for 4 weeks followed by SOD [GLN] for 12 weeks.</td></tr>
<tr class="Last"><td align="left" colspan="4">GROUP C: rhGH placebo + SOD [GLN] for 4 weeks followed by SOD [GLN] for 12 weeks.</td></tr>
<tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-2" href="#footnote-reference-2">*</a></dt>
<dd>SOD [GLNJ = Specialized Oral Diet supplemented with Glutamine; rhGH + SOD = Human Growth Hormone plus Specialized Oral Diet; rhGH + SOD [GLN] = Human Growth Hormone plus Specialized Oral</dd>
</dl></td></tr>
</tfoot>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left"><span class="Bold">Total Number of Subjects with At Least One Adverse Reaction</span></td>
<td class="Rrule" align="center" valign="bottom"><span class="Bold">12 (80)</span></td>
<td class="Rrule" align="center" valign="bottom"><span class="Bold">13 (81)</span></td>
<td class="Rrule" align="center" valign="bottom"><span class="Bold">7 (78)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Gastrointestinal System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">7 (47)</span></td>
<td class="Rrule" align="center"><span class="Bold">7 (44)</span></td>
<td class="Rrule" align="center"><span class="Bold">3 (33)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span></td>
<td class="Rrule" align="center">3 (20)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">2 (22)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">Abdominal Pain</span></td>
<td class="Rrule" align="center">3 (20)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Tenesmus</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">Pancreatitis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">Constipation</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Crohn's Disease Aggravated</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">Gastric Ulcer</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Gastrointestinal FistuIa</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Resistance Mechanism Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">6 (40)</span></td>
<td class="Rrule" align="center"><span class="Bold">5 (31)</span></td>
<td class="Rrule" align="center"><span class="Bold">5 (56)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="432545" conceptname="Bacterial infectious disease">Infection Bacterial</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">3 (33)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="40493255" conceptname="Viral syndrome">Infection Viral</span></td>
<td class="Rrule" align="center">3 (20)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span></td>
<td class="Rrule" align="center">1 (7)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="132797" conceptname="Sepsis">Sepsis</span></td>
<td class="Rrule" align="center">3 (20)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Body as a Whole: General Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (27)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">Fever</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">1 (6)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold"><span class="product-label-link" type="condition" conceptid="320136" conceptname="Disorder of respiratory system">Respiratory System Disorders</span></span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">Rhinitis</span></td>
<td class="Rrule" align="center">1 (7)</td>
<td class="Rrule" align="center">3 (19)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="24969" conceptname="Laryngitis">Laryngitis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4226263" conceptname="Pharyngitis">Pharyngitis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Reproductive Disorders, Female</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">4 (25)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  Vaginal <span class="product-label-link" type="condition" conceptid="432248" conceptname="Opportunistic mycosis">Fungal Infection</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Skin and Appendages Disorders</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">Rash</span></td>
<td class="Rrule" align="center">1 (7)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Musculoskeletal System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (13)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="77074" conceptname="Joint pain">Arthralgia</span></td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">2 (13)</td>
<td class="Rrule" align="center">0 (0)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Psychiatric Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (6)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">Depression</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">Insomnia</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Urinary System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">2 (22)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="198199" conceptname="Pyelonephritis">Pyelonephritis</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="201620" conceptname="Kidney stone">Renal Calculus</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Application Site Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4316202" conceptname="Injection site reaction">Injection Site Reaction</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Liver and Biliary System Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="4326594" conceptname="Abnormal liver function">Hepatic Function Abnormal</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"><span class="Bold">Vascular Extracardiac Disorders</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">0 (0)</span></td>
<td class="Rrule" align="center"><span class="Bold">1 (11)</span></td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left">  <span class="product-label-link" type="condition" conceptid="443784" conceptname="Vascular disorder">Vascular Disorder</span></td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">0 (0)</td>
<td class="Rrule" align="center">1 (11)</td>
</tr>
</tbody>
</table>
<p>During the initial 4-week treatment period, 100% of patients receiving growth hormone with and without glutamine reported at least one AR, whereas 89% of patients receiving growth hormone placebo with glutamine reported at least one AR. During weeks 5 to 18, 81% of patients receiving growth hormone with glutamine, 80% of patients receiving growth hormone without glutamine and 78% of patients receiving growth hormone placebo with glutamine experienced at least one AR. There were no <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">deaths</span> in this study.</p>
</div>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="S7"></a><a name="section-7"></a><p></p>
<h1>7 DRUG INTERACTIONS</h1>
<p class="First">Formal drug interaction studies have not been conducted.</p>
</div>
<div class="Section" data-sectionCode="43684-0">
<a name="S8"></a><a name="section-8"></a><p></p>
<h1>8 USE IN SPECIFIC POPULATIONS</h1>
<div class="Section" data-sectionCode="42228-7">
<a name="S8.1"></a><a name="section-8.1"></a><p></p>
<h2>8.1 Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-8.1.1"></a><p></p>
<p class="First"><span class="Italics">Teratogenic Effects: Pregnancy Category C</span></p>
<p>Animal reproduction studies have not been conducted with glutamine. It is also not known whether glutamine can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Glutamine should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="S8.2"></a><a name="section-8.2"></a><p></p>
<h2>8.2 Labor and Delivery</h2>
<p class="First">The effect of L-glutamine on labor and delivery is unknown.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="S8.3"></a><a name="section-8.3"></a><p></p>
<h2>8.3 Nursing Mothers</h2>
<p class="First">It is not known whether L-glutamine is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when L-glutamine is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="S8.4"></a><a name="section-8.4"></a><p></p>
<h2>8.4 Pediatric Use</h2>
<p class="First">The safety and effectiveness of L-glutamine in pediatric patients have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="S8.5"></a><a name="section-8.5"></a><p></p>
<h2>8.5 Geriatric Use</h2>
<p class="First">The clinical trial enrolled SBS patients between the ages of ZO and 75 years. Only 8 of the 41 subjects evaluated were ≥65 years of age. The clinical trial of oral glutamine did not include sufficient numbers of subjects aged 65 years and over to determine if they respond differently than younger subjects. In general, dose selection for an elderly patient should be individualized, because of the greater frequency of decreased hepatic, renal, or cardiac function, as well as concomitant disease in this population.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="S8.6"></a><a name="section-8.6"></a><p></p>
<h2>8.6 <span class="product-label-link" type="condition" conceptid="4212540" conceptname="Chronic liver disease">Hepatic Impairment</span></h2>
<p class="First">Glutamine is metabolized to glutamate and <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">ammonia</span>, which may increase in patients with hepatic dysfunction. Therefore, routine monitoring of hepatic function is recommended in patients receiving intravenous parental nutrition (IPN) and NutreStore.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="S8.7"></a><a name="section-8.7"></a><p></p>
<h2>8.7 <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">Renal Impairment</span></h2>
<p class="First">Glutamine is metabolized to glutamate and <span class="product-label-link" type="condition" conceptid="4184927" conceptname="Ammonia">ammonia</span>. Routine monitoring of renal function is recommended in patients receiving intravenous parental nutrition (IPN) and NutreStore.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="S10"></a><a name="section-9"></a><p></p>
<h1>10 OVERDOSAGE</h1>
<p class="First">Single oral doses of glutamine at about 20 to 22 g/kg, 8 to 11 g/kg, and 19 g/kg were lethal in mice, rats, and rabbits, respectively.</p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="S11"></a><a name="section-10"></a><p></p>
<h1>11 DESCRIPTION</h1>
<p class="First">NutreStore (L-glutamine powder for oral solution) for oral administration is formulated as a white crystalline powder in a paper-foil-plastic laminate packet. Each packet of NutreStore contains 5 g of L-glutamine. The amino acid glutamine is also known as (S)-2-aminoglutaramic acid, L-glutamic acid 5-amide, (S)-2,5-diamino-5-oxopentanoic acid, or L-glutamine. The molecular formula of glutamine is C<span class="Sub">5</span>H<span class="Sub">10</span>N<span class="Sub">2</span>O<span class="Sub">3</span>, and the molecular weight is 146.15 d. Glutamine has the following structural formula:</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cd3fb572-c5b1-43da-aea2-31208985f544&amp;name=nutrestore-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="S12"></a><a name="section-11"></a><p></p>
<h1>12 CLINICAL PHARMACOLOGY</h1>
<div class="Section" data-sectionCode="43679-0">
<a name="S12.1"></a><a name="section-11.1"></a><p></p>
<h2>12.1 Mechanism of Action</h2>
<p class="First">L-glutamine has important functions in regulation of gastrointestinal cell growth, function, and regeneration. Under normal conditions, glutamine concentration is maintained in the body by dietary intake and synthesis from endogenous glutamate. Data from clinical studies indicate that the role of and nutritional requirements for glutamine during catabolic illness, <span class="product-label-link" type="condition" conceptid="433633" conceptname="Late effect of superficial injury">trauma</span>, and <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> may differ significantly from the role of and nutritional requirements for glutamine in healthy individuals. Glutamine concentrations decrease and tissue glutamine metabolism increases during many catabolic disease states, and thus glutamine is often considered a "conditionally essential" amino acid.</p>
</div>
<div class="Section" data-sectionCode="43681-6">
<a name="S12.2"></a><a name="section-11.2"></a><p></p>
<h2>12.2 Pharmacodynamics</h2>
<p class="First">When glutamine was administered in combination with rhGH to rats, villous height, bowel growth, plasma insulin-like growth factor I, and body weight were significantly higher than in rats treated with either glutamine or rhGH alone.</p>
</div>
<div class="Section" data-sectionCode="43682-4">
<a name="S12.3"></a><a name="section-11.3"></a><p></p>
<h2>12.3 Pharmacokinetics</h2>
<p class="First">The pharmacokinetics of L-glutamine as described below are based on literature data in healthy subjects. The pharmacokinetics in patients with SBS have not been determined. The plasma glutamine concentrations in these patients following oral administration are expected to be highly variable depending on the length, segment, and presence/ absence of ileal-cecal valve for the remnant bowel.</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.1"></a><p></p>
<p class="First"><span class="Italics">Absorption</span></p>
<p>Following single dose oral administration of glutamine at 0.1 g/kg to six subjects, mean peak blood glutamine concentration was 1028 µM (or 150 mcg/mL) occurring approximately 30 minutes after administration. The pharmacokinetics following multiple oral doses have not been adequately characterized.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.2"></a><p></p>
<p class="First"><span class="Italics">Distribution</span></p>
<p>After an intravenous bolus dose in three subjects, the volume of distribution was estimated to be approximately 200 mL/kg.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.3"></a><p></p>
<p class="First"><span class="Italics">Metabolism</span></p>
<p>Endogenous glutamine participates in various metabolic activities, including the formation of glutamate, and synthesis of proteins, nucleotides, and amino sugars. Exogenous glutamine is anticipated to undergo similar metabolism.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.4"></a><p></p>
<p class="First"><span class="Italics">Elimination</span></p>
<p>Metabolism is the major route of elimination for glutamine. Although glutamine is eliminated by glomerular filtration, it is almost completely reabsorbed by the renal tubules. After an IV bolus dose in three subjects, the terminal half-life of glutamine was approximately 1 hour.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.5"></a><p></p>
<p class="First"><span class="Italics">Specific Populations</span></p>
<p>There are no studies to determine the effect of race, age, or gender on the pharmacokinetics of L-glutamine.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11.3.6"></a><p></p>
<p class="First"><span class="Italics">Drug-Drug Interactions</span></p>
<p>No drug-drug interaction studies have been conducted. Because metabolism of glutamine is mediated via non-CYP enzymes, glutamine pharmacokinetics are unlikely to be affected by other agents through CYP enzyme inhibition or induction.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="43680-8">
<a name="S13"></a><a name="section-12"></a><p></p>
<h1>13 NONCLINICAL TOXICOLOGY</h1>
<div class="Section" data-sectionCode="34083-6">
<a name="S13.1"></a><a name="section-12.1"></a><p></p>
<h2>13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals have not been performed to evaluate the carcinogenic potential of L-glutamine. Studies to evaluate its potential for impairment of fertility or its mutagenic potential have not been conducted.</p>
</div>
</div>
<div class="Section" data-sectionCode="34092-7">
<a name="S14"></a><a name="section-13"></a><p></p>
<h1>14 CLINICAL STUDIES</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="S14.1"></a><a name="section-13.1"></a><p></p>
<h2>14.1 Short Bowel Syndrome</h2>
<p class="First">A randomized, controlled, 3-arm, double-blind, parallel-group clinical study evaluated the efficacy and safety of oral glutamine as a cotherapy with rhGH in subjects with SBS who were dependent on intravenous parenteral nutrition (IPN) for nutritional support. The primary endpoint was the change in weekly total IPN volume defined as the sum of the volumes of lPN, supplemental lipid emulsion (SLE), and intravenous hydration fluid. The secondary endpoints were the change in weekly IPN caloric content and the change in the frequency of IPN administration per week.</p>
<p>All subjects received a specialized oral diet (SOD) for the duration of the study. Following a two-week equilibration period, treatment was administered in a double blind manner. Group A (N=16) received rhGH for four weeks plus oral glutamine placebo for 16 weeks, Group B (N=16) received rhGH for four weeks plus oral glutamine for 16 weeks, and Group C (N=9), received rhGH placebo for four weeks plus oral glutamine for 16 weeks. The efficacy of glutamine was assessed by comparing the cotherapy (rhGH and oral glutamine) to rhGH alone.</p>
<p>After 4 weeks of treatment with subcutaneous rhGH (0.1 mg/kg/d) and oral glutamine (30 g/ d) (Group B), subjects with SBS reduced their requirement for IPN volume (-7.7 L/wk), IPN caloric content (-5751 kcal/wk), and weekly frequency of IPN administration (-4.2 d/wk).</p>
<table width="100%">
<caption><span>Table 3 Results for Endpoints after 4 weeks of Treatment</span></caption>
<col align="left" valign="top" width="50%">
<col align="center" valign="top" width="15%">
<col align="center" valign="top" width="20%">
<col align="center" valign="top" width="15%">
<thead>
<tr class="First">
<th class="Lrule Rrule" align="left"></th>
<th class="Rrule" align="center">Group A</th>
<th class="Rrule" align="center">Group B</th>
<th class="Rrule" align="center">Group C</th>
</tr>
<tr class="Last">
<th class="Lrule Rrule" align="left"></th>
<th class="Rrule" align="center">rhGH + SOD <a name="footnote-reference-3" href="#footnote-3" class="Sup">*</a>
</th>
<th class="Rrule" align="center">rhGH + SOD[GLN] <a href="#footnote-3" class="Sup">*</a>
</th>
<th class="Rrule" align="center">SOD[GLN] <a href="#footnote-3" class="Sup">*</a>
</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="4">GROUP A: rhGH + SOD for 4 weeks followed by SOD for 12 weeks.</td></tr>
<tr><td align="left" colspan="4">GROUP B: rhGH + SOD [GLN] for 4 weeks followed by SOD [GLN] for 12 weeks.</td></tr>
<tr class="Last"><td align="left" colspan="4">GROUP C: rhGH placebo + SOD[GLN] for 4 weeks followed by SOD[GLN] for 12 weeks</td></tr>
<tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-3" href="#footnote-reference-3">*</a></dt>
<dd><span class="Bold">SOD[GLN] = Specialized Oral Diet supplemented with Glutamine; rhGH + SOD = Human Growth Hormone plus Specialized Oral Diet; rhGH + SOD[GLN] = Human Growth Hormone plus Specialized Oral Diet supplemented with Glutamine</span></dd>
<dt><a name="footnote-4" href="#footnote-reference-4">†</a></dt>
<dd><span class="Bold">p= 0.023, treatment comparison between rhGH + SOD[GLN] versus rhGH+SOD</span></dd>
</dl></td></tr>
</tfoot>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left"> </td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Total IPN volume (L/wk)</td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean at Baseline</span>
</td>
<td class="Rrule" align="center"><span class="Bold">10.3</span></td>
<td class="Rrule" align="center"><span class="Bold">10.5</span></td>
<td class="Rrule" align="center"><span class="Bold">13.5</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean Change</span>
</td>
<td class="Rrule" align="center"><span class="Bold">-5.9</span></td>
<td class="Rrule" align="center"><span class="Bold">-7.7<a name="footnote-reference-4" href="#footnote-4" class="Sup">†</a></span></td>
<td class="Rrule" align="center"><span class="Bold">-3.8</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"> </td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Total IPN Calories (kcal/wk)</td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean at Baseline</span>
</td>
<td class="Rrule" align="center"><span class="Bold">7634.7</span></td>
<td class="Rrule" align="center"><span class="Bold">7895.0</span></td>
<td class="Rrule" align="center"><span class="Bold">8570.4</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean Change</span>
</td>
<td class="Rrule" align="center"><span class="Bold"> -4338.3</span></td>
<td class="Rrule" align="center"><span class="Bold">-5751.2</span></td>
<td class="Rrule" align="center"><span class="Bold">-2633.3</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left"> </td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Frequency of IPN or SLE (days/week)</td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean at Baseline</span>
</td>
<td class="Rrule" align="center"><span class="Bold">5.1</span></td>
<td class="Rrule" align="center"><span class="Bold">5.4</span></td>
<td class="Rrule" align="center"><span class="Bold">5.9</span></td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">  <span class="Bold">Mean Change</span>
</td>
<td class="Rrule" align="center"><span class="Bold">-3.0</span></td>
<td class="Rrule" align="center"><span class="Bold">-4.2</span></td>
<td class="Rrule" align="center"><span class="Bold">-2.0</span></td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left"> </td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
<td class="Rrule" align="center"></td>
</tr>
</tbody>
</table>
<p>IPN volume requirements were Significantly reduced in subjects receiving subcutaneous rhGH and oral glutamine (Group B) when compared with IPN volume requirements in subjects receiving either treatment alone.</p>
<table width="100%">
<caption><span>Table 4 Persistence of Treatment Effect</span></caption>
<col align="left" valign="top" width="50%">
<col align="center" valign="top" width="15%">
<col align="center" valign="top" width="20%">
<col align="center" valign="top" width="15%">
<thead>
<tr class="Botrule First"><th class="Lrule Rrule" align="center" colspan="4">Change in lPN<a name="footnote-reference-5" href="#footnote-5" class="Sup">*</a> Volume, Calories, and Frequency<br>Week 2 to Week 18<br>lTT Population</th></tr>
<tr class="Last">
<th class="Lrule Rrule" align="center">Endpoint</th>
<th class="Rrule" align="center">Group A<br>[n = 16]</th>
<th class="Rrule" align="center">Group B<br>[n = 16]</th>
<th class="Rrule" align="center">Group C<br>[n = 9]</th>
</tr>
</thead>
<tfoot>
<tr class="First"><td align="left" colspan="4">GROUP A: rhGH + SOD for 4 weeks followed by SOD for 12 weeks.</td></tr>
<tr><td align="left" colspan="4">GROUP B: rhGH + SOD [GLN] for 4 weeks followed by SOD [GLN] for 12 weeks.</td></tr>
<tr class="Last"><td align="left" colspan="4">GROUP C: rhGH placebo + SOD[GLN] for 4 weeks followed yv SOD[GLN] for 12 weeks.</td></tr>
<tr><td colspan="4" align="left"><dl class="Footnote">
<dt><a name="footnote-5" href="#footnote-reference-5">*</a></dt>
<dd>IPN is Total lPN excluding supplemental lipid emulsion (SLE) and hydration fluid.</dd>
</dl></td></tr>
</tfoot>
<tbody>
<tr class="Botrule First">
<td class="Lrule Rrule" align="left">Change in weekly IPN Volume (L/wk)</td>
<td class="Rrule" align="center">-5.9</td>
<td class="Rrule" align="center">-7.2</td>
<td class="Rrule" align="center">-4.7</td>
</tr>
<tr class="Botrule">
<td class="Lrule Rrule" align="left">Change in weekly IPN Calories (kcal/wk)</td>
<td class="Rrule" align="center">-3522.2</td>
<td class="Rrule" align="center">-5347.3</td>
<td class="Rrule" align="center">-2254.0</td>
</tr>
<tr class="Last">
<td class="Lrule Rrule" align="left">Change in weekly IPN frequency (days/wk)</td>
<td class="Rrule" align="center">-2.9</td>
<td class="Rrule" align="center">-3.9</td>
<td class="Rrule" align="center">-1.9</td>
</tr>
</tbody>
</table>
<p>The change in weekly IPN volume, calories and frequency was assessed from Week 2 to Week 18. The data support that the treatment effect is maintained for 16 weeks. The efficacy of oral glutamine beyond 16 weeks of treatment has not been adequately studied.</p>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="S16"></a><a name="section-14"></a><p></p>
<h1>16 HOW SUPPLIED/STORAGE AND HANDLING</h1>
<p class="First">NutreStore is supplied in preprinted paper-foil-plastic laminate packets containing 5 g of L-glutamine powder and is supplied as follows:</p>
<ul class="Square"><li>Carton of 84 packets (NDC 42457-001-84)</li></ul>
<div class="Section" data-sectionCode="44425-7">
<a name="section-14.1"></a><p></p>
<p class="First">Store at 25°C (77°F) with excursions allowed to 15°-30°C (59°-86°F). [See USP Controlled Room Temperature]</p>
</div>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="S17"></a><a name="section-15"></a><p></p>
<h1>17 PATIENT COUNSELING INFORMATION</h1>
<p class="First">[See<a href="#PI"> FDA-approved patient labeling</a>]</p>
<div class="Section" data-sectionCode="42229-5">
<a name="S17.1"></a><a name="section-15.1"></a><p></p>
<h2>17.1 Dosing Instructions</h2>
<p class="First">NutreStore should be taken with meals or snacks at 2- to 3-hour intervals while awake. The volume of water may be varied according to the patient's preference. In the event of a patient's transient intolerance to oral intake, a dose may be delayed for up to 2 hours.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-16"></a><p></p>
<p class="First"><span class="Bold">For additional information concerning NutreStore, contact:</span></p>
<p><span class="Bold">Manufactured for:<br>Emmaus<br>MEDICAL, INC.</span></p>
<p>20725 S. Western Ave., Suite 136<br>Torrance, CA 90501-1884<br>Tel: 1-877-420-6493<br>www.nutrestore.com</p>
<p>© 2013 Emmaus Medical, Inc.</p>
</div>
<div class="Section" data-sectionCode="42230-3">
<a name="PI"></a><a name="section-17"></a><p></p>
<p class="First">FDA-Approved Patient Labeling</p>
<p><span class="Bold">Patient Information</span></p>
<p><span class="Bold">NutreStore<span class="Sup">®</span></span> (NOO-tre-stor)<br><span class="Bold">[L-glutamine powder for oral solution] </span>(GLOO-tah-min)</p>
<p>Please read this leaflet carefully before you start to use NutreStore<span class="Sup">®</span> and each time your prescription is refilled since there may be new information. The information in this leaflet does not take the place of regularly talking with your doctor or health care professional.</p>
<p><span class="Bold">What is NutreStore<span class="Sup">®</span>?</span></p>
<p>NutreStore<span class="Sup">®</span> is the amino acid L-glutamine, identical to the L-glutamine that your body produces. NutreStore<span class="Sup">®</span> is used together with a human growth hormone, approved for treating short bowel syndrome [SBS], in patients receiving a specialized diet tailored to meet their individual needs.</p>
<p><span class="Bold">Why has my doctor prescribed NutreStore<span class="Sup">®</span>?</span></p>
<p>Your doctor prescribed NutreStore<span class="Sup">®</span> initially in combination with human growth hormone to help decrease your need for intravenous feedings. After treatment in combination with human growth hormone, you will continue to take NutreStore<span class="Sup">®</span> alone to maintain the treatment effect. During your treatment with NutreStore<span class="Sup">®</span> you will be taking up to 6 packets of NutreStore<span class="Sup">®</span> a day. You will also receive instructions from your doctor or a dietitian on the proper diet you should follow during this treatment period as well as after your treatment is over. Please refer to the patient package leaflet available for human growth hormone for more information on how to take human growth hormone.</p>
<p><span class="Bold">What should I tell my doctor before taking NutreStore<span class="Sup">®</span>?</span></p>
<p>Tell your doctor about all of your conditions including if you:</p>
<ul class="Disc">
<li>are pregnant or planning to become pregnant. It is not known if NutreStore® can harm your unborn baby.</li>
<li>are breast feeding. It is not known if NutreStore<span class="Sup">®</span> passes into your milk and if it can harm your baby. You should talk to your doctor about breastfeeding while taking NutreStore<span class="Sup">®</span>.</li>
<li>have liver or kidney problems. Your doctor may do blood tests to check your liver and kidney function while you are taking NutreStore<span class="Sup">®</span>.</li>
<li>are older than 65 years of age. Your dose of NutreStore<span class="Sup">®</span> may need to be adjusted.</li>
</ul>
<p>Tell your doctor about all the medicines you take including prescription medicines, non-prescription medicines, vitamins, or herbal supplements. It is not known if NutreStore<span class="Sup">®</span> and other medicines can affect each other.</p>
<p><span class="Bold">What should I avoid while taking NutreStore<span class="Sup">®</span>?</span></p>
<ul class="Disc">
<li>
<span class="Bold">Pregnancy. </span>You should talk to your doctor if you are planning to become pregnant while taking NutreStore<span class="Sup">®</span>. It is not known whether NutreStore<span class="Sup">®</span> can affect the ability of a woman to become pregnant. It is also not known whether NutreStore<span class="Sup">®</span> can cause harm to a fetus when taken by a pregnant woman or if NutreStore<span class="Sup">®</span> has an effect on labor and delivery.</li>
<li>
<span class="Bold">Breastfeeding. </span>You should talk to your doctor before breastfeeding an infant while taking NutreStore<span class="Sup">®</span>. It is not known whether the glutamine in NutreStore<span class="Sup">®</span> can be passed to an infant in mother's milk, and it is not clear whether the drug could harm the infant if it is passed in mother's milk.</li>
</ul>
<p><span class="Bold">What are the possible side effects of NutreStore<span class="Sup">®</span>?</span></p>
<p>Many patients taking NutreStore<span class="Sup">®</span> and human growth hormone for the treatment of SBS experience side effects.</p>
<p>Whether or not you experience side effects, you and your doctor should periodically talk about your general health.</p>
<ul class="Square"><li>Your doctor may want to monitor you more closely and ask you to have blood tests done more frequently.</li></ul>
<p><span class="Bold">Digestive system.</span></p>
<p>The possible side effects you may experience while taking NutreStore<span class="Sup">®</span> include <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="194382" conceptname="External hemorrhoids">hemorrhoids</span>, <span class="product-label-link" type="condition" conceptid="4192640" conceptname="Pancreatitis">pancreatitis</span>, aggravation of Crohn's disease, <span class="product-label-link" type="condition" conceptid="4265600" conceptname="Gastric ulcer">gastric ulcer</span>, and <span class="product-label-link" type="condition" conceptid="4295370" conceptname="Gastrointestinal fistula">gastrointestinal fistula</span> (opening between stomach and intestine).</p>
<p>The possible related symptoms you may experience while taking NutreStore<span class="Sup">®</span> include urge to empty bowel, gas, <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal pain</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="4226991" conceptname="Aptyalism">dry mouth</span> and <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>.</p>
<p>These side effects and related symptoms may be similar to those you have experienced while being treated for SBS. You should talk to your doctor about these problems before starting an over-the-counter medication to treat these symptoms. It is important for you to follow your doctor's or dietitian's instructions on the type of diet best for you.</p>
<p>Please refer also to the patient package leaflet available for human growth hormone for more information on the possible benefits and side effects of human growth hormone.</p>
<p>Tell your doctor about any side effects that bother you or that do not go away.</p>
<p>These are not all the side effects with NutreStore<span class="Sup">®</span>. For more information, ask your doctor or pharmacist.</p>
<p><span class="Bold">How should I take NutreStore<span class="Sup">®</span>?</span></p>
<p>NutreStore<span class="Sup">®</span> should be taken up to 6 times a day (every 2 to 3 hours during the day) with a meal or snack. This should be continued every day for as long as your doctor prescribes. Each dose of NutreStore<span class="Sup">®</span> should be prepared by pouring the contents of one packet into an 8-oz glass of water and stirring for approximately 1 minute. After stirring, you should drink the NutreStore<span class="Sup">®</span> within 2 hours. If you miss a dose, you should take your next dose as soon as you remember or are able to take it. Do not take more than 6 packets each day.</p>
<p class="Bold">What kind of food should I eat during my treatment with NutreStore<span class="Sup">®</span>?</p>
<p>Your doctor or dietitian will prescribe for you the types and quantities of foods you should eat during your treatment with NutreStore<span class="Sup">®</span>. These foods are not special and can be purchased from your local market. Your likes and dislikes should be taken into consideration when your meal plan is created.</p>
<p>Your doctor or dietitian will advise you on how many times a day you should eat. Your doctor or dietitian will adjust your diet as needed during your treatment with NutreStore<span class="Sup">®</span>. It is important that you carefully follow the eating plan your doctor or dietitian gives you.</p>
<p><span class="Bold">Storage conditions for NutreStore<span class="Sup">®</span></span></p>
<p>Packets of NutreStore<span class="Sup">®</span> should be stored at room temperature (25°C / 77°F). Expiration dates are stated on product labels. Do not use any damaged packets of NutreStore<span class="Sup">®</span>. Keep NutreStore<span class="Sup">®</span> and all medicines out of the reach of children.</p>
<p><span class="Bold">General information about prescription medicines</span></p>
<p>This medication has been prescribed for a particular medical condition. Do not use it for another condition or give this drug to anyone else. If you have any questions, you should speak with your doctor or health care professional. You may also ask your doctor or pharmacist for a copy of the information provided to them with the product. Keep this and all drugs out of the reach of children.</p>
<p>For additional information, you may call the NutreStore<span class="Sup">®</span> patient hotline at 1-877-420-6493.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-18"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">PRINCIPAL DISPLAY PANEL - 84 Packet Carton</span></p>
<p><span class="Bold">NutreStore<span class="Sup">®</span></span><br>[L-glutamine powder for oral solution]</p>
<div class="Figure"><img alt="Principal Display Panel - 84 Packet Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=cd3fb572-c5b1-43da-aea2-31208985f544&amp;name=nutrestore-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NUTRESTORE 		
					</strong><br><span class="contentTableReg">glutamine powder, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:42457-001</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>glutamine</strong> (glutamine) </td>
<td class="formItem">glutamine</td>
<td class="formItem">5 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:42457-001-84</td>
<td class="formItem">84  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:42457-001-01</td>
<td class="formItem">1  in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:42457-001-18</td>
<td class="formItem">18  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:42457-001-11</td>
<td class="formItem">1  in 1 PACKET</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA021667</td>
<td class="formItem">06/04/2008</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Emmaus Medical, Inc.
							(784073434)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">AndersonBrecon Inc.</td>
<td class="formItem"></td>
<td class="formItem">053217022</td>
<td class="formItem">PACK(42457-001)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Kyowa Hakko Bio Co., Ltd.</td>
<td class="formItem"></td>
<td class="formItem">690598751</td>
<td class="formItem">API MANUFACTURE(42457-001)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 7/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>7f1b4835-29e7-43a6-892f-db57fcb621ea</div>
<div>Set id: cd3fb572-c5b1-43da-aea2-31208985f544</div>
<div>Version: 2</div>
<div>Effective Time: 20140715</div>
</div>
</div> <div class="DistributorName">Emmaus Medical, Inc.</div></p>
</body></html>
